Skip to content

Gastroenterology

Viberzi Samples for Healthcare Providers

Explore medication sample resources and treatment access support for clinicians prescribing Viberzi® (eluxadoline tablets).

Generic Name:eluxadoline tablets
Manufacturer:AbbVie
Indication:mixed opioid receptor modulator for IBS-D

Viberzi® (eluxadoline) is a prescription medication indicated for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults. It is administered as an oral tablet and works by acting on opioid receptors within the gastrointestinal tract. Viberzi® may be prescribed to help reduce abdominal pain and improve bowel-related symptoms associated with IBS-D.

Built to help reduce friction around treatment access & patient care.

Request Viberzi® (eluxadoline tablets) sample support and treatment access assistance through DocUpdate Concierge.

Request Samples Through DocUpdate
DocUpdate app - request Viberzi samples

DocUpdate provides free HIPAA-compliant mobile tools that move care forward.

Frequently Asked Questions About Viberzi Samples

Healthcare providers can download the DocUpdate app and submit a request through Concierge for medication sample and treatment access support.

Viberzi is an oral medication used for adults with irritable bowel syndrome with diarrhea.

Viberzi may be prescribed for irritable bowel syndrome with diarrhea in adults.

DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.

No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.

Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.

Download DocUpdate to request other samples

Download Now